The week's coverage from MIT Technology Review spans several distinct frontiers. One piece reports on a live Roundtables event that asked whether AI could really kill us all, including the threat of bioweapons. Another notes that AI chiefs including Dario Amodei, Sam Altman, Elon Musk, and Demis Hassabis have suddenly all embraced doomer rhetoric, suggesting a broader shift in how industry leaders talk about their own technology.
A separate story describes a mouse whose brain cortex is made up of human cells, with multiple cameras tracking the animal as it moved around an arena. That is not an AI story, but it is another example of humans reshaping the boundaries of living systems. A third piece looks at the economics: a finance professor assessed what is at stake in AI's trillion-dollar gamble, while OpenAI makes a bid for biological data.
These sources are not in disagreement; they are simply separate stories about different parts of the technology landscape. Together, they illustrate a moment when AI, biology, and finance are converging in ways that raise both practical and philosophical questions for society.